CHRONIC FATIQUE SYNDROME: Genetically Engineered Mosquito release in Ontario, Florida, the Cayman Islands

The trial of the OX513A strain of the dengue-carrying Aedes aegypti mosquito, developed by UK biotechnology company Oxitec, was carried out on Grand Cayman island by the Cayman Islands’ Mosquito Research and Control Unit (MRCU) in 2009, followed by a bigger release between May and October this year. Together they represent the first known release … Continue reading CHRONIC FATIQUE SYNDROME: Genetically Engineered Mosquito release in Ontario, Florida, the Cayman Islands